Organization and Description of Business (Details) - USD ($) |
Aug. 01, 2018 |
Apr. 30, 2025 |
Jan. 31, 2025 |
Jan. 31, 2024 |
Aug. 31, 2020 |
|---|---|---|---|---|---|
| Organization and Description of Business [Line Items] | |||||
| Royalty, percentage | 6.00% | ||||
| Common stock value | $ 11,130 | $ 11,075 | $ 8,860 | ||
| 4P Therapeutics LLC [Member] | |||||
| Organization and Description of Business [Line Items] | |||||
| Acquired costs | $ 2,250,000 | ||||
| Common stock value | 400,000 | ||||
| 4P Therapeutics LLC [Member] | Intellectual Property [Member] | |||||
| Organization and Description of Business [Line Items] | |||||
| Acquired costs | 400,000 | ||||
| Pocono Pharmaceuticals [Member] | |||||
| Organization and Description of Business [Line Items] | |||||
| Acquired percentage | 100.00% | ||||
| Common Stock [Member] | 4P Therapeutics LLC [Member] | |||||
| Organization and Description of Business [Line Items] | |||||
| Acquired costs | $ 1,850,000 | ||||
| Acquired common stock shares (in Shares) | 250,000 | ||||
| Common stock value | $ 1,850,000 |
| X | ||||||||||
- Definition Royalty percentage. No definition available.
|
| X | ||||||||||
- Definition Amount of transaction cost incurred to effect business combination. Excludes separately recognized transaction and indirect cost. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of shares of equity interest issued or issuable by acquirer as part of consideration transferred in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of voting equity interest acquired in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|